0001994336-23-000001.txt : 20230926 0001994336-23-000001.hdr.sgml : 20230926 20230926171112 ACCESSION NUMBER: 0001994336-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230926 DATE AS OF CHANGE: 20230926 EFFECTIVENESS DATE: 20230926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hillhurst Biopharmaceuticals, Inc. CENTRAL INDEX KEY: 0001994336 IRS NUMBER: 460859130 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-493089 FILM NUMBER: 231281194 BUSINESS ADDRESS: STREET 1: 2029 VERDUGO BOULEVARD, #125 CITY: MONTROSE STATE: CA ZIP: 91020 BUSINESS PHONE: (818) 445-5890 MAIL ADDRESS: STREET 1: 2029 VERDUGO BOULEVARD, #125 CITY: MONTROSE STATE: CA ZIP: 91020 D 1 primary_doc.xml X0708 D LIVE 0001994336 Hillhurst Biopharmaceuticals, Inc. 2029 VERDUGO BOULEVARD, #125 MONTROSE CA CALIFORNIA 91020 (818) 445-5890 DELAWARE None None Corporation true Andrew Gomperts 2029 Verdugo Boulevard #125 Montrose CA CALIFORNIA 91020 Executive Officer Director Edward Gomperts 2029 Verdugo Boulevard #125 Montrose CA CALIFORNIA 91020 Executive Officer Director Jeff Friedman 2029 Verdugo Boulevard #125 Montrose CA CALIFORNIA 91020 Director Biotechnology Decline to Disclose 06b false 2023-09-11 false true false 0 1837500 1837500 0 false 10 0 0 0 false Hillhurst Biopharmaceuticals, Inc. Andrew Gomperts Andrew Gomperts Chief Executive Officer 2023-09-25